Use of isavuconazole in mucormycosis: a systematic review
Abstract Background Mucormycosis is an opportunistic fungal infection which is associated with poor prognosis. Only a few antifungals are available in the arsenal against mucormycosis. The global guidelines for diagnosing and managing mucormycosis recommend high doses of liposomal amphotericin B (LA...
Saved in:
Main Authors: | Shobha Sanjeewani Gunathilaka, Reshani Kaumada Keragala, Kasun Madhumal Gunathilaka, Sujanthi Wickramage, Sachithra Ravindi Bandara, Indika Sanjeewa Senevirathne, Asela Sampath Jayaweera |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-025-10439-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Effectiveness and Safety of Isavuconazole Versus Amphotericin B for Patients with Invasive Mucormycosis
by: Jiayuan Qin, et al.
Published: (2025-01-01) -
Pulmonary Mucormycosis – An Experience from a Tertiary Care Center in Southern India: A PULM MUCOR Study
by: Ashwin Oliver Arul, et al.
Published: (2025-01-01) -
Endoscopic Orbital Clearance/Debridement: A Potential Substitute for Orbital Exenteration in Rhino-orbital Mucormycosis
by: Ahmed Hassan Sweed, et al.
Published: (2025-01-01) -
Sinonasal mucormycosis with an unusual involvement of palate
by: Santosh Kumar Swain
Published: (2022-01-01) -
Maxillary mucormycosis masquerading as an endodontic-periodontal lesion
by: Abubacker Afreen Jannath, et al.
Published: (2024-07-01)